CLINICAL TRIALS PROFILE FOR DEFERIPRONE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for DEFERIPRONE
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| New Formulation | NCT02442310 ↗ | Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers | Completed | Algorithme Pharma Inc | Phase 1 | 2015-05-01 | The purpose of this study is to look at the pharmacokinetics of a new formulation of deferiprone (deferiprone delayed release tablets) under fed and fasting conditions. |
| New Formulation | NCT02442310 ↗ | Comparison of Deferiprone Delayed Release Tablets and Deferiprone Oral Solution in Healthy Volunteers | Completed | ApoPharma | Phase 1 | 2015-05-01 | The purpose of this study is to look at the pharmacokinetics of a new formulation of deferiprone (deferiprone delayed release tablets) under fed and fasting conditions. |
| New Formulation | NCT02465489 ↗ | Comparison of Deferiprone Extended Release Tablets and Ferriprox Immediate Release Tablets in Healthy Volunteers | Completed | ApoPharma | Phase 1 | 2015-06-01 | The purpose of this study is to look at the pharmacokinetics of a new formulation of deferiprone (deferiprone extended release tablets) under fed and fasting conditions. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for DEFERIPRONE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000588 ↗ | Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 | 1989-06-01 | To demonstrate the safety and effectiveness of orally-administered pyridoxal isonicotinoyl hydrazone (PIH) for the chronic treatment of iron overload. |
| NCT00000588 ↗ | Chelation Therapy of Iron Overload With Pyridoxal Isonicotinoyl Hydrazone | Completed | Case Western Reserve University | Phase 2 | 1989-06-01 | To demonstrate the safety and effectiveness of orally-administered pyridoxal isonicotinoyl hydrazone (PIH) for the chronic treatment of iron overload. |
| NCT00000623 ↗ | Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 2000-07-01 | The purpose of the TCRN is to accelerate research in the management of thalassemia, standardize existing treatments, and evaluate new ones in a network of clinical centers in North America. The emphasis will be on clinical trials that help identify optimal therapy. Therapeutic trials may involve investigational drugs, drugs already approved but not currently used, and drugs currently used. | |
| NCT00000623 ↗ | Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) | Completed | Thalassemia Clinical Research Network | 2000-07-01 | The purpose of the TCRN is to accelerate research in the management of thalassemia, standardize existing treatments, and evaluate new ones in a network of clinical centers in North America. The emphasis will be on clinical trials that help identify optimal therapy. Therapeutic trials may involve investigational drugs, drugs already approved but not currently used, and drugs currently used. | |
| NCT00000623 ↗ | Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) | Completed | HealthCore-NERI | 2000-07-01 | The purpose of the TCRN is to accelerate research in the management of thalassemia, standardize existing treatments, and evaluate new ones in a network of clinical centers in North America. The emphasis will be on clinical trials that help identify optimal therapy. Therapeutic trials may involve investigational drugs, drugs already approved but not currently used, and drugs currently used. | |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DEFERIPRONE
Condition Name
Clinical Trial Locations for DEFERIPRONE
Trials by Country
Clinical Trial Progress for DEFERIPRONE
Clinical Trial Phase
Clinical Trial Sponsors for DEFERIPRONE
Sponsor Name
